Clinical Trial Imaging Services Market, valued at USD 1.31 billion in 2023, is expected to grow at a compound annual growth rate of 5.4 ...

Rhythm Technologies announced new research emphasizing the clinical and health-economic advantages of its Zio LTCM system.

The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.

Artificial intelligence is making impressive strides in its ability to read medical images. In a recent test in Britain's ...

Using an artificial intelligence program to read echocardiograms may reduce the wait time for results and help lead to more ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

Clatterbridge was the first cancer research centre in the UK to give an injection of the Transgene experimental immunotherapy ...

Researchers optimized healthcare AI for diagnoses, analyzed gender bias in image searches and found tiny DNA circles that ...

After treatment with white button mushroom extract in mice and patients with prostate cancer, scientists discovered a decline ...

In the first ever human clinical study, replacing refined sugars with the same amount of pure maple syrup for 5% of daily energy intake resulted in improved glycemic response, lower systolic blood ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

The ASUNCTIS trial evaluated asunercept's safety and efficacy in COVID-19, showing trends toward faster recovery despite not ...